Get started
Work

TABLE 2 from Mathematical Modeling Identifies Optimum Palbociclib-fulvestrant Dose Administration Schedules for the Treatment of Patients with Estrogen Receptor–positive Breast Cancer

Year: 2023
Type: other
Abstract: IC50s versus G1–S TR50 of palbociclib and fulvestrant
DOI: 10.1158/2767-9764.24574039
Authors: Yu-Chen Cheng, Shayna Stein, Agostina Nardone, Weihan Liu, Wen Ma, Gabriella Cohen, Cristina Guarducci, Thomas O. McDonald, Rinath Jeselsohn, Franziska Michor
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4388723111
Cites:
Cited by:
Related to: 10